Sort

Search

11/02/2024 Criteria and indicators to evaluate quality of care in genitourinary tumour boards
Puente, J, Arrea, FA, Rueda, OB, Gauna, DC, Durán, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Pardo, GS, Casas, JAV, Gratal, P, Pardo, MT, Porta, VG. Criteria and indicators to evaluate quality of care in genitourinary tumour boards. Clinical & Translational Oncology. 2024; 26(7)DOI:10.1007/s12094-024-03381-z. PMID:38341809. IF:2.500(Q3/6D).
10/02/2024 Clinical practice guideline on the management of vestibular schwannoma.
Lassaletta L, Acle Cervera L, Altuna X, Amilibia Cabeza E, Arístegui Ruiz M, Batuecas Caletrio Á, Benítez Del Rosario J, Cabanillas Farpón R, Costales Marcos M, Escada P, Espinosa-Sánchez JM, García Leal R, Gavilán J, Gómez Martínez J, González-Aguado R, Martinez-Glez V, Guerra Jiménez G, Harguindey Antolí-Candela A, Hernández García BJ, Orús Dotú C, Polo López R, Manrique M, Martín Sanz E, Martínez Álvarez R, Martínez H, Martínez-Martínez M, Rey-Martinez J, Ropero Romero F, Santa Cruz Ruiz S, Vallejo LÁ, Soto Varela A, Varela-Nieto I, Morales Puebla JM. Clinical practice guideline on the management of vestibular schwannoma.. Acta Otorrinolaringologica Espanola. 2024; 75(2)DOI:10.1016/j.otoeng.2023.10.005. PMID:38346489. IF:(Q/D).
09/02/2024 Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration
Piñol-Jurado, P, Verdú-Díaz, J, Fernández-Simón, E, Domínguez-González, C, Hernández-Lain, A, Lawless, C, Vincent, A, González-Chamorro, A, Villalobos, E, Monceau, A, Laidler, Z, Mehra, P, Clark, J, Filby, A, Mcdonald, D, Rushton, P, Bowey, A, Perez, JA, Tasca, G, Marini-Bettolo, C, Guglieri, M, Straub, V, Suarez-Calvet, X, Diaz-Manera, J. Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-51906-x. PMID:38336890. IF:3.900(Q1/2D).
09/02/2024 Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD
Pascual-Goñi, E, Collet, R, Tejada-Illa, C, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Novelli, S, López-Pardo, J, Sanfeliu, AE, Mariscal, A, Gargallo, YA, Martínez-Hernández, E, Cocho, D, Querol, L. Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(7)DOI:10.1136/jnnp-2023-332443. PMID:38341197. IF:7.500(Q1/1D).